University of Michigan Rogel Cancer Center | Strategic Alliance Partners

Latest from University of Michigan Rogel Cancer Center

Dr. Farrington on the Importance of Genetic Testing in CRC

October 13, 2020

Video

Caroline Farrington, PhD, discusses the importance of genetic testing in colorectal cancer.

Family History Plays Key Role in Germline Testing for Hereditary Breast and Ovarian Cancers

October 12, 2020

Article

Sofia D. Merajver, MD, PhD, discusses the importance of germline testing in patients with breast and ovarian cancer along with how this testing is being used to personalize treatment.

Identifying Genetic Variants, Matching With Targeted Therapies Serve as Next Great Challenge With Germline Testing in Oncology

October 12, 2020

Article

Goutham Narla, MD, PhD, discusses the revolution of genetic testing and how it has led to more accurate and widespread assays for patients with cancer.

Patient Advocacy and Education Are Essential for Optimal Cancer Care

October 11, 2020

Article

Caroline Farrington, PhD, shares her insight as both a researcher and a cancer survivor on the importance of patient advocacy, as well as the proper resources to aid patients through a cancer diagnosis.

PARP Inhibitors Underscore the Need for Routine Germline Testing in Prostate Cancer

September 29, 2020

Article

Ajjai Shivaram Alva, MBBS, discusses the role of PARP inhibitors in prostate cancer, the importance of germline testing, and the need for personalized medicine.

Dr. Vaishampayan on the Safety of Tivozanib Versus Sorafenib in RCC

September 15, 2020

Video

Ulka N. Vaishampayan, MBBS, FAB, discusses the safety of tivozanib versus sorafenib in advanced renal cell carcinoma.